Literature DB >> 2535682

Different growth responses to agents which elevate cAMP in human melanoma cell lines of high and low experimental metastatic capacity.

E J Ormerod1, I R Hart.   

Abstract

Human melanoma variants of low and high experimental metastatic activity, which had been derived from the same parental line, showed markedly different growth responses to agents which elevated intracellular cAMP. The high metastatic line had a significant decrease in in vitro proliferation following treatment with cholera toxin (10(-9) M) and forskolin (100 microM), with both agents causing virtual cessation of cell growth after 3-5 days incubation. Pre-treatment with 10(-9) M cholera toxin reduced colony forming ability to 11-15 per cent of control values, saturation densities were decreased to 10-25 per cent of controls and these cytostatic responses were accompanied by changes in cellular morphology. Lung colonising capacity of this cell line after i.v. injection into athymic mice was reduced significantly by prior exposure to cholera toxin (a median of 2 lung nodules versus 26 lung nodules for untreated, control cells). In contrast, low metastatic cell lines showed no significant growth inhibition in the presence of these agents. Cholera toxin (10(-9) M) reduced colony forming ability of these cells to only 74 per cent of control values and there were no significant decreases in growth rate nor any morphological changes in response to either cholera toxin or forskolin. The variable response obtained in the cell lines appeared neither to be a consequence of variation in induced levels of intracellular cAMP nor in differences between the cell lines in response to the same agent; forskolin (100 microM) induced a maximal 25-fold elevation and cholera toxin (10(-9) M) a 2.5-fold elevation increase in cAMP. These data show that highly metastatic variants of a human melanoma cell line differ from their less metastatic counterparts in the way they respond to agents which elevate the second messenger molecule cAMP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535682     DOI: 10.1007/bf02057183

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  39 in total

1.  cAMP metabolism in B16 melanoma clones during the formation of experimental and spontaneous metastases.

Authors:  B R Lester; R G Greig; C Buscarino; J R Sheppard; S P Corwin; G Poste
Journal:  Int J Cancer       Date:  1986-09-15       Impact factor: 7.396

2.  Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages.

Authors:  R Bravo; M Neuberg; J Burckhardt; J Almendral; R Wallich; R Müller
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

3.  Response of mouse melanoma cells to melanocyte stimulating hormone.

Authors:  G Wong; J Pawelek; M Sansone; J Morowitz
Journal:  Nature       Date:  1974-03-22       Impact factor: 49.962

4.  A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth.

Authors:  D C Bennett; P J Cooper; I R Hart
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

5.  Relative responsiveness of cultured human epidermal melanocytes and melanoma cells to selected mitogens.

Authors:  P R Gordon; V D Treloar; M A Vrabel; B A Gilchrest
Journal:  J Invest Dermatol       Date:  1986-12       Impact factor: 8.551

6.  Inhibition of clonogenic growth of melanoma cells by combination of melanocyte stimulating hormone and theophylline.

Authors:  M M Wick
Journal:  J Invest Dermatol       Date:  1981-09       Impact factor: 8.551

7.  Characterization of cyclic AMP-resistant Chinese hamster ovary cell mutants lacking type I protein kinase.

Authors:  T J Singh; C Roth; M M Gottesman; I H Pastan
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

8.  Enhanced experimental metastatic capacity of a human tumor line following treatment with 5-azacytidine.

Authors:  E J Ormerod; C A Everett; I R Hart
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

9.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.

Authors:  M R Montminy; L M Bilezikjian
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

10.  Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells.

Authors:  K B Seamon; W Padgett; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  7 in total

1.  Changes in protein expression during melanoma differentiation determined by computer analysis of 2-D gels.

Authors:  D Easty; I R Hart; K Patel; C Seymour; M Yacoub; A Domscheit; S Gunther; W Postel; A Gorg; M J Dunn
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

2.  The regulation of cyclic AMP production and the role of cyclic AMP in B16 melanoma cells of differing metastatic potential.

Authors:  S E Hill; R C Rees; S MacNeil
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

3.  A positive association between agonist-induced cyclic AMP production in vitro and metastatic potential in murine B16 melanoma and hamster fibrosarcoma.

Authors:  S E Hill; R C Rees; S MacNeil
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

4.  Forskolin protects keratinocytes from UVB-induced apoptosis and increases DNA repair independent of its effects on melanogenesis.

Authors:  Thierry Passeron; Takeshi Namiki; Hélène J Passeron; Elodie Le Pape; Vincent J Hearing
Journal:  J Invest Dermatol       Date:  2008-06-26       Impact factor: 8.551

5.  Growth and invasion of human melanomas in human skin grafted to immunodeficient mice.

Authors:  I Juhasz; S M Albelda; D E Elder; G F Murphy; K Adachi; D Herlyn; I T Valyi-Nagy; M Herlyn
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Epac increases melanoma cell migration by a heparan sulfate-related mechanism.

Authors:  Erdene Baljinnyam; Kousaku Iwatsubo; Reiko Kurotani; Xu Wang; Coskun Ulucan; Mizuka Iwatsubo; David Lagunoff; Yoshihiro Ishikawa
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-05       Impact factor: 4.249

7.  Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.

Authors:  Kenichi Hiramoto; Taku Murata; Kasumi Shimizu; Hiroshi Morita; Madoka Inui; Vincent C Manganiello; Toshiro Tagawa; Naoya Arai
Journal:  Cell Signal       Date:  2014-04-03       Impact factor: 4.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.